Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.
NEOPLASIA/Myeloid leukemias and dysplasias
NEOPLASIA/myeloid leukemias and dysplasias: Genetic and other predisposing conditions
bone marrow failure
familial MDS/acute leukemia
telomere biology disorder
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
13 10 2020
13 10 2020
Historique:
received:
25
03
2020
accepted:
11
08
2020
entrez:
9
10
2020
pubmed:
10
10
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Telomere biology disorders (TBDs) present heterogeneously, ranging from infantile bone marrow failure associated with very short telomeres to adult-onset interstitial lung disease (ILD) with normal telomere length. Yield of genetic testing and phenotypic spectra for TBDs caused by the expanding list of telomere genes in adults remain understudied. Thus, we screened adults aged ≥18 years with a personal and/or family history clustering hematologic disorders and/or ILD enrolled on The University of Chicago Inherited Hematologic Disorders Registry for causative variants in 13 TBD genes. Sixteen (10%) of 153 probands carried causative variants distributed among TERT (n = 6), TERC (n = 4), PARN (n = 5), or RTEL1 (n = 1), of which 19% were copy number variants. The highest yield (9 of 22 [41%]) was in families with mixed hematologic and ILD presentations, suggesting that ILD in hematology populations and hematologic abnormalities in ILD populations warrant TBD genetic testing. Four (3%) of 117 familial hematologic disorder families without ILD carried TBD variants, making TBD second to only DDX41 in frequency for genetic diagnoses in this population. Phenotypes of 17 carriers with heterozygous PARN variants included 4 (24%) with hematologic abnormalities, 67% with lymphocyte telomere lengths measured by flow cytometry and fluorescence in situ hybridization at or above the 10th percentile, and a high penetrance for ILD. Alternative etiologies for cytopenias and/or ILD such as autoimmune features were noted in multiple TBD families, emphasizing the need to maintain clinical suspicion for a TBD despite the presence of alternative explanations.
Identifiants
pubmed: 33035329
pii: S2473-9529(20)31221-0
doi: 10.1182/bloodadvances.2020001721
pmc: PMC7556157
doi:
Substances chimiques
Telomerase
EC 2.7.7.49
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
4873-4886Subventions
Organisme : NIMH NIH HHS
ID : R01 MH083989
Pays : United States
Organisme : NHLBI NIH HHS
ID : R03 HL145253
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197458
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
© 2020 by The American Society of Hematology.
Références
Haematologica. 2016 Nov;101(11):1343-1350
pubmed: 27418648
Haematologica. 2015 Jan;100(1):42-8
pubmed: 25239263
Nature. 1999 Dec 2;402(6761):551-5
pubmed: 10591218
N Engl J Med. 2007 Mar 29;356(13):1317-26
pubmed: 17392301
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1187-92
pubmed: 19147845
Nat Genet. 2015 Dec;47(12):1482-8
pubmed: 26482878
Hepatology. 2011 May;53(5):1608-17
pubmed: 21520174
Biol Blood Marrow Transplant. 2016 Jul;22(7):1152-1158
pubmed: 26968789
Chest. 2011 Sep;140(3):753-763
pubmed: 21349926
Sci Transl Med. 2016 Aug 10;8(351):351ra107
pubmed: 27510903
J Clin Invest. 2015 Feb;125(2):563-70
pubmed: 25562321
Blood. 2011 May 26;117(21):5607-11
pubmed: 21436073
Haematologica. 2018 Jan;103(1):30-39
pubmed: 29051281
J Heart Lung Transplant. 2015 Apr;34(4):538-46
pubmed: 25612863
Genes (Basel). 2016 Sep 03;7(9):
pubmed: 27598205
Genet Med. 2020 Feb;22(2):245-257
pubmed: 31690835
Eur Respir J. 2014 Jul;44(1):178-87
pubmed: 24833766
Bone Marrow Transplant. 2017 May;52(5):765-768
pubmed: 28092351
Eur Respir J. 2017 May 11;49(5):
pubmed: 28495692
Am J Respir Crit Care Med. 2019 Aug 1;200(3):336-347
pubmed: 30566847
F1000Res. 2018 May 1;7:
pubmed: 29770205
Curr Opin Genet Dev. 2015 Aug;33:1-9
pubmed: 26232116
Autoimmun Rev. 2010 Aug;9(10):646-51
pubmed: 20435169
Genet Med. 2018 Sep;20(9):1054-1060
pubmed: 29300386
Leukemia. 2017 May;31(5):1226-1229
pubmed: 28104920
Eur Respir J. 2019 Feb 7;53(2):
pubmed: 30523160
Genet Med. 2018 Dec;20(12):1687-1688
pubmed: 29543229
Br J Haematol. 2012 Jul;158(2):242-248
pubmed: 22533337
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7552-7
pubmed: 17460043
J Heart Lung Transplant. 2017 Aug;36(8):845-853
pubmed: 28262440
J Heart Lung Transplant. 2015 Oct;34(10):1318-24
pubmed: 26169663
Eur Respir J. 2016 Dec;48(6):1710-1720
pubmed: 27540018
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2358-E2365
pubmed: 29463756
Haematologica. 2012 Mar;97(3):353-9
pubmed: 22058220
Nat Genet. 2015 May;47(5):512-7
pubmed: 25848748
J Clin Invest. 2015 May;125(5):2151-60
pubmed: 25893599
Chest. 2015 Jun;147(6):1549-1557
pubmed: 25393420
Blood. 2007 Sep 1;110(5):1439-47
pubmed: 17468339
N Engl J Med. 2005 Apr 7;352(14):1413-24
pubmed: 15814878
Blood. 2003 Aug 1;102(3):916-8
pubmed: 12676774
Aging Dis. 2011 Dec;2(6):524-37
pubmed: 22396899
J Med Genet. 2015 Nov;52(11):738-48
pubmed: 26342108
Hum Mutat. 2018 Nov;39(11):1531-1541
pubmed: 30095857
Nat Protoc. 2006;1(5):2365-76
pubmed: 17406480
Am J Respir Crit Care Med. 2019 Feb 1;199(3):362-376
pubmed: 30088779
Nat Rev Genet. 2019 May;20(5):299-309
pubmed: 30760854
Blood. 2020 May 28;135(22):1946-1956
pubmed: 32076714
Genet Med. 2010 Dec;12(12):753-64
pubmed: 21189492
RNA Biol. 2016 Aug 2;13(8):696-706
pubmed: 26400640
Eur Respir J. 2015 Aug;46(2):474-85
pubmed: 26022962
Genes Dev. 2019 Oct 1;33(19-20):1381-1396
pubmed: 31488579
Aging Cell. 2013 Apr;12(2):319-23
pubmed: 23279657
Hum Mutat. 2019 Dec;40(12):2414-2429
pubmed: 31448843
Genet Med. 2018 Sep;20(9):918-926
pubmed: 29988079
Hepatology. 2011 May;53(5):1600-7
pubmed: 21520173